There was no prognostic value associated with high ZFAS1 expression in the KRASMT population (adjusted HR = 0.65 (95% CI 0.34–1.24)), although there was a significant association with lower relapse rates in the WT/WT population (adjusted HR = 0.47 (95% CI 0.24–0.92)) (Supplementary Figure 4B, Supplementary Table 3) indicating an opposing prognostic role in these distinct tumor genotypes. This evidence concerns the gene ZFAS1 and neoplasm.